1Forbes CD. Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination. ESPS Investigators. European Stroke Prevention Study. Thromb Res, 1998,92:S1-6.
2International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet,1997,349:1569-1581.
3CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Collaborative Group, CAST(Chinese Acute Stroke Trial). Lancet, 1997, 349: 1641-1649.
4Paul SF, Karyn M, Cynthia DL. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J Ethnopharmacology,1996, 50:131-139.
5Pierr S, Jamme I, Robert K, et al. Ginkgo biloba extract(EGb 761) protects Na,K-ATPase isoenzymes during cerebral ischemia. Cell Mol Biol,2002,48:671-679.
6Barber PA, Auer RN, Buchan AM, et al. Understanding and managing ischemic stroke. Can J Physiol Pharmacol, 2001, 79:283-296.
7Hickenbottom SL, Grotta J. Neuroprotective therapy. Semin Neurol,1998,18:485-492.
